Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Oosten AW"'
Autor:
Agema BC; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy (B.C.P.K., S.L.W.K.), Erasmus MC University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group (B.C.P.K.), Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: b.agema@erasmusmc.nl., Vrielink K; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Tienen F; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Geijteman ECT; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Van der Rijt CCD; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Koch BCP; Department of Clinical Pharmacy (B.C.P.K., S.L.W.K.), Erasmus MC University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group (B.C.P.K.), Erasmus University Medical Center, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy (B.C.P.K., S.L.W.K.), Erasmus MC University Medical Center, Rotterdam, The Netherlands., Oosten AW; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Journal of pain and symptom management [J Pain Symptom Manage] 2024 Dec; Vol. 68 (6), pp. e491-e499. Date of Electronic Publication: 2024 Aug 29.
Autor:
Giraud EL; Department of Pharmacy, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: https://twitter.com/ElineGirau45556., Westerdijk K; Department of Medical Oncology, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands., van der Kleij MBA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Guchelaar NAD; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Meertens M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Rieborn A; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Roets E; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Keizer-Heldens P; Department of Medical Oncology, Rijnstate Hospital, Arnhem, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Erp NP; Department of Pharmacy, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Ingrid.desar@radboudumc.nl.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103477. Date of Electronic Publication: 2024 Jun 03.
Autor:
van de Wal D; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., den Hollander D; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Husson O; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. w.t.a.vandergraaf@erasmusmc.nl.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands. w.t.a.vandergraaf@erasmusmc.nl.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Apr 10; Vol. 32 (5), pp. 279. Date of Electronic Publication: 2024 Apr 10.
Autor:
van de Wal D; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands., den Hollander D; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Husson O; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, the Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
International journal of clinical and health psychology : IJCHP [Int J Clin Health Psychol] 2024 Jan-Mar; Vol. 24 (1), pp. 100434. Date of Electronic Publication: 2024 Jan 09.
Autor:
van de Wal D; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Doorn B; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., den Hollander D; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacology, The Netherlands Cancer Institute, The Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Husson O; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, The Netherlands.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1616-1624. Date of Electronic Publication: 2023 Nov 25.
Autor:
Brink P; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Kalisvaart GM; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: G.M.Kalisvaart@lumc.nl., Schrage YM; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Ijzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Wal T; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., de Geus-Oei LF; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands., Hartgrink HH; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Grunhagen DJ; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Verhoef C; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Oosten AW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Been LB; Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands., van Ginkel RJ; Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Bonenkamp HJ; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van Houdt WJ; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Fiocco M; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Mathematical Institute, Leiden University, Leiden, the Netherlands., van der Hage JA; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2023 Sep; Vol. 49 (9), pp. 106942. Date of Electronic Publication: 2023 May 23.
Autor:
Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, Leiden, 2300 RC, The Netherlands. m.mohammadi@lumc.nl., IJzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Hollander DD; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Targeted oncology [Target Oncol] 2023 May; Vol. 18 (3), pp. 415-423. Date of Electronic Publication: 2023 Apr 20.
Autor:
Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands. m.mohammadi@lumc.nl., Jansen-Werkhoven TM; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Ijzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., den Hollander D; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Publikováno v:
Targeted oncology [Target Oncol] 2022 Nov; Vol. 17 (6), pp. 627-634. Date of Electronic Publication: 2022 Nov 14.
Autor:
Younger E; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Division of Clinical Studies, Institute of Cancer Research, London, UK., den Hollander D; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Soomers VLMN; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., Benson C; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK., Young RJ; Academic Unit of Clinical Oncology, The University of Sheffield, Sheffield, UK., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Haan JJ; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Miah A; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Division of Clinical Studies, Institute of Cancer Research, London, UK., Zaidi S; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Husson O; Division of Clinical Studies, Institute of Cancer Research, London, UK; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: olga.husson@icr.ac.uk., van der Graaf WTA; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
ESMO open [ESMO Open] 2021 Oct; Vol. 6 (5), pp. 100258. Date of Electronic Publication: 2021 Sep 09.
Autor:
Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: m.mohammadi@lumc.nl., IJzerman NS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hohenberger P; Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, University of Heidelberg, Germany., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland., Jones RL; The Royal Marsden NHS Foundation Trust / Institute of Cancer Research, London, UK., Martin-Broto J; Medical Oncology Department, Virgen del Rocio University Hospital, Seville, Spain., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium., Vassos N; Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, University of Heidelberg, Germany., Farag S; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK., Baia M; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., van Sandick JW; Department of Surgical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands., Bastiaannet E; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Schrage Y; Department of Surgical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands; European School of Soft Tissue Sarcoma Surgery, Amsterdam, the Netherlands.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2021 Aug; Vol. 47 (8), pp. 2173-2181. Date of Electronic Publication: 2021 Mar 31.